NEW YORK March 14 - Silico Insights is collaborating with Ashni Naturaceuticals to identify regulatory and post-translational pathways from genomics and proteomics data, the companies said Wednesday. 

Under the terms of the partnership, Silico Insights of Woburn, Mass., will apply its iSight bio informatics platform to establish dependencies and pathways from research data generated by Ashni. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.